dexcom glp-1 and CGM: Why Ozempic Users Are Turning to the Stelo (2026 – Pump Peelz Why Dexcom Diabetes CGM Technology

Scientifically Backed for Real Results: Clinical studies show that 10g (the amount in 4 tsp) helps promote satiety within 30 minutes after a meal and helps maintain appetite control for up to 4 hours.* Designed for convenient daily use

Carmot Therapeutics has revealed preliminary data from the single ascending dose (SAD) portion of its ongoing Phase 1 clinical trial for CT-996, an oral small molecule GLP-1 receptor agonist (RA) currently being evaluated in a first-in-human clinical trial in participants with obesity or overweight.CT-996 is a once-daily oral, small molecule GLP-1 receptor agonist being developed for the treatment of obesity and type 2 diabetes (T2D)

Our GLP-1 programs are doctor-supported

Here's what it means.

You need more protein during weight loss but you often feel like eating less food

Easy-to-read information on each side of the box